【摘 要】
：
Objective To observe the clinical curative effect in childrens heavy bronchitis pneumonia accompanied with cardiac failure by the treatment of the two different methods of abstention with phentolamine
【机 构】
：
Department of Pediatrics,252 Hospital of PLA,Baoding,Hebei 071051,China
论文部分内容阅读
Objective To observe the clinical curative effect in childrens heavy bronchitis pneumonia accompanied with cardiac failure by the treatment of the two different methods of abstention with phentolamine.Methods Eighty one cases in childrens pneumonia accompanied with cardiac failure.Were stochastically divided into treatment group 1 (24 cases, treated by infusion with phentolamine) and treatment group 2 (30 cases treated by continuos pump with phentolamine), and control group, (27 cases, without phentolamine).The controlgroup was conventionally treated by anti□□ infection, antiasthrnatic effect and cardiac strength.Based on the treatment above, treatment group 1 takes the intravenous injection into murphs dropper with phentolamine, and group 2 takes the intravenous infuseion with phentolamine.The clinical efficacy of the three groups of patients, cough disappearance time, wheezing disappearance time, pulmonary rales disappeared time and adverse reactions were observed.Results Cough disappearance time was no significant difference in treatment group 1 and treatment group 2.Wheezing disappeared time and pulmonary rales disappeared time in the treatment group 2 were shorter than those in the treatment group 1 [(5.9±0.8)d vs (6.8±1.1) d, (6.3 ±0.9) d vs (6.8 ±0.9) d, P<0.05].Effective rate in the treatment group 2 was higher than the control group and treatment group 1 [96.7%(26/30) vs 91.7%(22/24), 85.2%(23/27)] , effective rate in the treatment group 1 was higher than the control group, differences were statistically significant(all P<0.05).Conclusion Children with bronchial pneumonia and congestive heart failure treated by intravenous drip infusion pump phentolamine, wheezing disappeared time and pulmonary rales disappeared time were shorten.There was no adverse reactions such as nasal resistance, irritability, increased heart rate.
其他文献
Backround Mice are widely used to study arterial disease in man, and the pathogenesis of arterial diseases is known to be highly influenced by hemodynamic factors.Transient animal computational fluid
Objectives Toanalysequantitativelya lya vortex motion in isovolumic contraction phase during a cardiac cycle by echocardiographicvector flow mapping (VFM) of left ventricular flow.Background The role
Objectives To quantify a vortex motion in left ventricular flow by Echocardiographic vector flow mapping (VFM).Background In vitro or vivo flow patterns studies have suggestedthe presence of vortices
Objective To investigate the synergetic effects of panax notoginseng saponins (PNS) and ginkgetin on Proinflammatory cytokines in Rats with Hyperlipidemia, and explore the clinical significance.Method
Objective To explore protection of carbachol to myocardium in patients with intestinal barrier dysfunction induced by emergency trauma.Methods Seventy patients after trauma with a definite diagnosis o
目的 采用冠状动脉CT血管造影监测评价阿托伐他汀对冠状动脉硬化斑块治疗效果.方法 选取经冠状动脉CT血管成像证实管腔狭窄程度＜50％的高胆固醇血症患者80例,完全随机分为观察组和对照组,各40例.观察组口服阿托伐他汀(10 mg/次,1次/d)和阿司匹林治疗,对照组给予单纯阿司匹林治疗.检测治疗前及治疗12个月后血脂和冠状动脉CT血管成像,观察2组患者治疗前后冠状动脉粥样硬化斑块的变化.结果 ①治
Background This small study has determined the effect of vitamin Con myocardial reperfusion inpatients undergoing elective percutaneous coronary intervention (PCI).This study was to explore whether an
Background The association between body weight and clinical prognosis in patients with coronary artery disease (CAD) have not been defmitely proved.We conducted a meta-analysis to determine the extent
Background chronic kidney disease (CKD) is a strong predictor of mortality and subsequent cardiac events after percutaneous coronary intervention.The safety and efficacy of drug-eluting stent (DES) in
Background Obesity is a major risk factor for developing coronary artery disease.It is less clear whether obesity accelerates progression of disease among those with established coronary disease.The o